Utilization of a tetrahydro-pyrimdoazepine core as a bioisosteric replacement for a piperazine-urea resulted in the discovery a novel series of potent antagonists of TRPV1. The tetrahydro-pyrimdoazepines have been identified as having good in vitro and in vivo potency and acceptable physical properties.
利用四氢
嘧啶并氮杂卓核作为
哌嗪-
尿素的
生物等效替代物,导致发现了一系列新的TRPV1强效拮抗剂。已经确定四氢
嘧啶并氮杂卓具有良好的体外和体内效力以及可接受的物理性质。